SILVERARC CAPITAL MANAGEMENT, LLC Q3 2025 Filing
Filed November 12, 2025
Portfolio Value
$741.6B
Holdings
82
Report Date
Q3 2025
Filing Type
13F-HR
All Holdings (82 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ABVXABIVAX SA | 539,704 | $45.8B | 6.18% | |
| 2 | RYTMRHYTHM PHARMACEUTICALS INC | 369,996 | $37.4B | 5.04% | |
| 3 | RNAAVIDITY BIOSCIENCES INC | 844,633 | $36.8B | 4.96% | |
| 4 | NUVLNUVALENT INC | 372,300 | $32.2B | 4.34% | |
| 5 | URGNUROGEN PHARMA LTD | 1,577,283 | $31.5B | 4.24% | |
| 6 | AKROAKERO THERAPEUTICS INC | 643,636 | $30.6B | 4.12% | |
| 7 | IM8NINSMED INC | 206,648 | $29.8B | 4.01% | |
| 8 | DNTHDIANTHUS THERAPEUTICS INC | 674,966 | $26.6B | 3.58% | |
| 9 | QUREUNIQURE NV | 455,000 | $26.6B | 3.58% | |
| 10 | CGONCG ONCOLOGY INC | 638,346 | $25.7B | 3.47% | |
| 11 | UTHRUNITED THERAPEUTICS CORP DEL | 59,900 | $25.1B | 3.39% | Put |
| 12 | ORICORIC PHARMACEUTICALS INC | 1,948,808 | $23.4B | 3.15% | |
| 13 | CDTXCIDARA THERAPEUTICS INC | 220,902 | $21.2B | 2.85% | |
| 14 | GUTSFRACTYL HEALTH INC | 10,600,000 | $16.9B | 2.27% | |
| 15 | KALVKALVISTA PHARMACEUTICALS INC | 1,363,378 | $16.6B | 2.24% | |
| 16 | KODKODIAK SCIENCES INC | 1,000,000 | $16.4B | 2.21% | |
| 17 | RAREULTRAGENYX PHARMACEUTICAL IN | 528,200 | $15.9B | 2.14% | Call |
| 18 | GOSSGOSSAMER BIO INC | 4,779,082 | $12.6B | 1.69% | |
| 19 | COGTCOGENT BIOSCIENCES INC | 815,075 | $11.7B | 1.58% | |
| 20 | CYTKCYTOKINETICS INC | 211,000 | $11.6B | 1.56% | |
| 21 | PCVXVAXCYTE INC | 314,339 | $11.3B | 1.53% | |
| 22 | BIIBBIOGEN INC | 80,419 | $11.3B | 1.52% | |
| 23 | ASNDASCENDIS PHARMA A/S | 53,554 | $10.6B | 1.44% | |
| 24 | CMPXCOMPASS THERAPEUTICS INC | 2,833,988 | $9.9B | 1.34% | |
| 25 | AMLXAMYLYX PHARMACEUTICALS INC | 700,000 | $9.5B | 1.28% | |
| 26 | VSTMVERASTEM INC | 1,042,757 | $9.2B | 1.24% | |
| 27 | AVTXAVALO THERAPEUTICS INC | 720,922 | $9.2B | 1.24% | |
| 28 | OLMAOLEMA PHARMACEUTICALS INC | 933,541 | $9.1B | 1.23% | |
| 29 | TCE2CELLDEX THERAPEUTICS INC NEW | 348,922 | $9.0B | 1.22% | |
| 30 | SRRKSCHOLAR ROCK HLDG CORP | 233,920 | $8.7B | 1.17% | |
| 31 | VCYTVERACYTE INC | 235,791 | $8.1B | 1.09% | |
| 32 | SNDXSYNDAX PHARMACEUTICALS INC | 463,708 | $7.1B | 0.96% | |
| 33 | RAPPRAPPORT THERAPEUTICS INC | 203,946 | $6.1B | 0.82% | |
| 34 | VRDNVIRIDIAN THERAPEUTICS INC | 259,509 | $5.6B | 0.76% | |
| 35 | ALKSALKERMES PLC | 180,513 | $5.4B | 0.73% | |
| 36 | TRVITREVI THERAPEUTICS INC | 588,789 | $5.4B | 0.73% | |
| 37 | BBOTBRIDGEBIO ONCOLOGY THERAPEUT | 457,414 | $5.3B | 0.71% | |
| 38 | ABEOABEONA THERAPEUTICS INC | 994,754 | $5.3B | 0.71% | |
| 39 | LXEOLEXEO THERAPEUTICS INC | 778,611 | $5.2B | 0.70% | |
| 40 | COGTCOGENT BIOSCIENCES INC | 360,000 | $5.2B | 0.70% | Call |
| 41 | GLUEMONTE ROSA THERAPEUTICS INC | 694,942 | $5.1B | 0.69% | |
| 42 | CGENCOMPUGEN LTD | 3,311,165 | $4.9B | 0.66% | |
| 43 | PHVSPHARVARIS N V | 183,903 | $4.6B | 0.62% | |
| 44 | CELCCELCUITY INC | 88,686 | $4.4B | 0.59% | |
| 45 | CERSCERUS CORP | 2,715,786 | $4.3B | 0.58% | |
| 46 | CCCCC4 THERAPEUTICS INC | 1,897,383 | $4.2B | 0.57% | |
| 47 | TELATELA BIO INC | 2,782,923 | $4.1B | 0.56% | |
| 48 | AARDAARDVARK THERAPEUTICS INC | 306,912 | $4.1B | 0.55% | |
| 49 | BCAXBICARA THERAPEUTICS INC | 250,606 | $4.0B | 0.53% | |
| 50 | BNTCBENITEC BIOPHARMA INC | 276,267 | $3.9B | 0.52% | |
| 51 | KNSAKINIKSA PHARMACEUTICALS INTL | 88,910 | $3.5B | 0.47% | |
| 52 | CNTACENTESSA PHARMACEUTICALS PLC | 141,238 | $3.4B | 0.46% | |
| 53 | EYPTEYEPOINT PHARMACEUTICALS INC | 230,837 | $3.3B | 0.44% | |
| 54 | SIONSIONNA THERAPEUTICS INC | 108,801 | $3.2B | 0.43% | |
| 55 | ZURAZURA BIO LTD | 720,452 | $3.1B | 0.42% | |
| 56 | MLYSMINERALYS THERAPEUTICS INC | 80,000 | $3.0B | 0.41% | |
| 57 | ERASERASCA INC | 1,368,075 | $3.0B | 0.40% | |
| 58 | PRAXPRAXIS PRECISION MEDICINES I | 51,210 | $2.7B | 0.37% | |
| 59 | ELUTELUTIA INC | 2,850,987 | $2.5B | 0.34% | |
| 60 | DCTHDELCATH SYS INC | 203,386 | $2.2B | 0.29% | |
| 61 | CRNXCRINETICS PHARMACEUTICALS IN | 50,000 | $2.1B | 0.28% | |
| 62 | CAMPCAMP4 THERAPEUTICS CORP | 653,594 | $2.0B | 0.26% | |
| 63 | CTNMCONTINEUM THERAPEUTICS INC | 166,161 | $2.0B | 0.26% | |
| 64 | DYNDYNE THERAPEUTICS INC | 100,000 | $1.3B | 0.17% | |
| 65 | LBRXLB PHARMACEUTICALS INC | 70,000 | $1.1B | 0.15% | |
| 66 | CAPRCAPRICOR THERAPEUTICS INC | 144,700 | $1.0B | 0.14% | Put |
| 67 | MRSNMERSANA THERAPEUTICS INC | 133,636 | $1.0B | 0.14% | |
| 68 | RADXRADIOPHARM THERANOSTICS LTD | 187,406 | $1.0B | 0.14% | |
| 69 | ATYRATYR PHARMA INC | 1,250,000 | $901.3M | 0.12% | Put |
| 70 | IMVTIMMUNOVANT INC | 50,000 | $806.0M | 0.11% | |
| 71 | ARCTARCTURUS THERAPEUTICS HLDGS | 42,000 | $774.1M | 0.10% | Put |
| 72 | SNDXSYNDAX PHARMACEUTICALS INC | 50,000 | $769.5M | 0.10% | Call |
| 73 | RAREULTRAGENYX PHARMACEUTICAL IN | 25,000 | $752.0M | 0.10% | Put |
| 74 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 65,000 | $466.1M | 0.06% | Call |
| 75 | MODDMODULAR MED INC | 639,531 | $447.5M | 0.06% | |
| 76 | BDSXBIODESIX INC | 49,607 | $374.5M | 0.05% | |
| 77 | MBXMBX BIOSCIENCES INC | 15,000 | $262.5M | 0.04% | |
| 78 | ELVNENLIVEN THERAPEUTICS INC | 10,675 | $218.5M | 0.03% | |
| 79 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 30,000 | $215.1M | 0.03% | |
| 80 | ARCTARCTURUS THERAPEUTICS HLDGS | 3,445 | $63.5M | 0.01% | |
| 81 | NKTRNEKTAR THERAPEUTICS | 365 | $20.8M | 0.00% | |
| 82 | RCKTWROCKET PHARMACEUTICALS INC | 104,828 | $4.1M | 0.00% |